nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—DGUOK—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.0134	0.177	CbGpPWpGaD
Nelarabine—POLA1—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.00955	0.624	CbGdCrCtD
Nelarabine—Adenosine triphosphate—ALK—peripheral nervous system neoplasm	0.00581	0.522	CrCbGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—BARD1—peripheral nervous system neoplasm	0.0046	0.0611	CbGpPWpGaD
Nelarabine—Adenosine triphosphate—AKT1—peripheral nervous system neoplasm	0.00454	0.407	CrCbGaD
Nelarabine—ADA—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00444	0.0589	CbGpPWpGaD
Nelarabine—DCK—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.0041	0.0543	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—BARD1—peripheral nervous system neoplasm	0.00337	0.0447	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—CD34—peripheral nervous system neoplasm	0.00317	0.042	CbGpPWpGaD
Nelarabine—DCK—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	0.00298	0.195	CbGdCrCtD
Nelarabine—DCK—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	0.00276	0.18	CbGdCrCtD
Nelarabine—DGUOK—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00259	0.0344	CbGpPWpGaD
Nelarabine—DGUOK—trigeminal ganglion—peripheral nervous system neoplasm	0.00201	0.21	CbGeAlD
Nelarabine—ADA—p73 transcription factor network—NTRK1—peripheral nervous system neoplasm	0.00196	0.026	CbGpPWpGaD
Nelarabine—DGUOK—parotid gland—peripheral nervous system neoplasm	0.00189	0.198	CbGeAlD
Nelarabine—DGUOK—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00175	0.0232	CbGpPWpGaD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—peripheral nervous system neoplasm	0.00157	0.0208	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.00146	0.0194	CbGpPWpGaD
Nelarabine—ADA—Validated transcriptional targets of TAp63 isoforms—CDKN2A—peripheral nervous system neoplasm	0.0014	0.0186	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GNS—peripheral nervous system neoplasm	0.00127	0.0168	CbGpPWpGaD
Nelarabine—POLA1—trigeminal ganglion—peripheral nervous system neoplasm	0.00124	0.13	CbGeAlD
Nelarabine—DGUOK—Metabolism—NME1—peripheral nervous system neoplasm	0.00121	0.0161	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—COX2—peripheral nervous system neoplasm	0.00117	0.0155	CbGpPWpGaD
Nelarabine—POLA1—parotid gland—peripheral nervous system neoplasm	0.00117	0.122	CbGeAlD
Nelarabine—ADA—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.00104	0.0139	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000985	0.0131	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.00093	0.0123	CbGpPWpGaD
Nelarabine—DGUOK—cerebellum—peripheral nervous system neoplasm	0.000876	0.0918	CbGeAlD
Nelarabine—ADA—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000861	0.0114	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000795	0.0105	CbGpPWpGaD
Nelarabine—Adenosine triphosphate—ABCB1—peripheral nervous system neoplasm	0.000792	0.0711	CrCbGaD
Nelarabine—DGUOK—Metabolism—ENO2—peripheral nervous system neoplasm	0.000768	0.0102	CbGpPWpGaD
Nelarabine—DCK—trigeminal ganglion—peripheral nervous system neoplasm	0.000764	0.08	CbGeAlD
Nelarabine—POLA1—E2F transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000744	0.00987	CbGpPWpGaD
Nelarabine—DCK—parotid gland—peripheral nervous system neoplasm	0.00072	0.0755	CbGeAlD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000718	0.00952	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—NRAS—peripheral nervous system neoplasm	0.000716	0.0095	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—MYC—peripheral nervous system neoplasm	0.000701	0.00929	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—MYC—peripheral nervous system neoplasm	0.000667	0.00885	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000654	0.00867	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—BCHE—peripheral nervous system neoplasm	0.000649	0.0086	CbGpPWpGaD
Nelarabine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000634	0.000713	CcSEcCtD
Nelarabine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000633	0.000712	CcSEcCtD
Nelarabine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000633	0.000712	CcSEcCtD
Nelarabine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000631	0.00071	CcSEcCtD
Nelarabine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000629	0.000708	CcSEcCtD
Nelarabine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000625	0.000703	CcSEcCtD
Nelarabine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000625	0.000703	CcSEcCtD
Nelarabine—Pain in extremity—Epirubicin—peripheral nervous system neoplasm	0.000624	0.000702	CcSEcCtD
Nelarabine—Osteoarthritis—Epirubicin—peripheral nervous system neoplasm	0.000624	0.000702	CcSEcCtD
Nelarabine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000623	0.000701	CcSEcCtD
Nelarabine—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000623	0.000701	CcSEcCtD
Nelarabine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000623	0.000701	CcSEcCtD
Nelarabine—Anaemia—Etoposide—peripheral nervous system neoplasm	0.00062	0.000697	CcSEcCtD
Nelarabine—DGUOK—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000619	0.0082	CbGpPWpGaD
Nelarabine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000618	0.000696	CcSEcCtD
Nelarabine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000617	0.000694	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000615	0.000692	CcSEcCtD
Nelarabine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000612	0.000688	CcSEcCtD
Nelarabine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000612	0.000688	CcSEcCtD
Nelarabine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000611	0.000687	CcSEcCtD
Nelarabine—DGUOK—Metabolism—TH—peripheral nervous system neoplasm	0.00061	0.00809	CbGpPWpGaD
Nelarabine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000609	0.000686	CcSEcCtD
Nelarabine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000606	0.000682	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000605	0.000681	CcSEcCtD
Nelarabine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000604	0.00068	CcSEcCtD
Nelarabine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.0006	0.000675	CcSEcCtD
Nelarabine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000599	0.000674	CcSEcCtD
Nelarabine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000599	0.000674	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000599	0.00794	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.000599	0.00794	CbGpPWpGaD
Nelarabine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000598	0.000672	CcSEcCtD
Nelarabine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000598	0.000672	CcSEcCtD
Nelarabine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000597	0.000672	CcSEcCtD
Nelarabine—Infection—Cisplatin—peripheral nervous system neoplasm	0.000593	0.000668	CcSEcCtD
Nelarabine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000593	0.000667	CcSEcCtD
Nelarabine—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000592	0.000666	CcSEcCtD
Nelarabine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000589	0.000663	CcSEcCtD
Nelarabine—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000589	0.000663	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000589	0.00781	CbGpPWpGaD
Nelarabine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000588	0.000662	CcSEcCtD
Nelarabine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000588	0.000662	CcSEcCtD
Nelarabine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000587	0.000661	CcSEcCtD
Nelarabine—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000587	0.00066	CcSEcCtD
Nelarabine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000586	0.000659	CcSEcCtD
Nelarabine—Cough—Etoposide—peripheral nervous system neoplasm	0.000585	0.000658	CcSEcCtD
Nelarabine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000585	0.000658	CcSEcCtD
Nelarabine—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000585	0.000658	CcSEcCtD
Nelarabine—Headache—Topotecan—peripheral nervous system neoplasm	0.000584	0.000657	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000583	0.000656	CcSEcCtD
Nelarabine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000582	0.000655	CcSEcCtD
Nelarabine—ADA—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000582	0.00771	CbGpPWpGaD
Nelarabine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000581	0.000654	CcSEcCtD
Nelarabine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00058	0.000653	CcSEcCtD
Nelarabine—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.00058	0.000653	CcSEcCtD
Nelarabine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000579	0.000652	CcSEcCtD
Nelarabine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000579	0.000652	CcSEcCtD
Nelarabine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000578	0.00065	CcSEcCtD
Nelarabine—Pain—Vincristine—peripheral nervous system neoplasm	0.000578	0.00065	CcSEcCtD
Nelarabine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000578	0.00065	CcSEcCtD
Nelarabine—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000577	0.00065	CcSEcCtD
Nelarabine—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000577	0.00065	CcSEcCtD
Nelarabine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000573	0.000645	CcSEcCtD
Nelarabine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000571	0.000642	CcSEcCtD
Nelarabine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000569	0.000641	CcSEcCtD
Nelarabine—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000568	0.000639	CcSEcCtD
Nelarabine—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000562	0.000632	CcSEcCtD
Nelarabine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000558	0.000628	CcSEcCtD
Nelarabine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000554	0.000624	CcSEcCtD
Nelarabine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000554	0.000624	CcSEcCtD
Nelarabine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000554	0.000623	CcSEcCtD
Nelarabine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000552	0.000622	CcSEcCtD
Nelarabine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000552	0.000621	CcSEcCtD
Nelarabine—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.00055	0.000619	CcSEcCtD
Nelarabine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000549	0.000618	CcSEcCtD
Nelarabine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000549	0.000618	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000544	0.000612	CcSEcCtD
Nelarabine—Infection—Etoposide—peripheral nervous system neoplasm	0.000544	0.000612	CcSEcCtD
Nelarabine—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000543	0.000611	CcSEcCtD
Nelarabine—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000543	0.000611	CcSEcCtD
Nelarabine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000542	0.00061	CcSEcCtD
Nelarabine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000542	0.00061	CcSEcCtD
Nelarabine—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000541	0.000609	CcSEcCtD
Nelarabine—POLA1—cerebellum—peripheral nervous system neoplasm	0.00054	0.0566	CbGeAlD
Nelarabine—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000537	0.000604	CcSEcCtD
Nelarabine—DCK—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000537	0.00712	CbGpPWpGaD
Nelarabine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000536	0.000603	CcSEcCtD
Nelarabine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000536	0.000603	CcSEcCtD
Nelarabine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000534	0.000601	CcSEcCtD
Nelarabine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000534	0.000601	CcSEcCtD
Nelarabine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000532	0.000599	CcSEcCtD
Nelarabine—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000525	0.000591	CcSEcCtD
Nelarabine—ADA—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	0.000524	0.00695	CbGpPWpGaD
Nelarabine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000522	0.000587	CcSEcCtD
Nelarabine—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00052	0.000585	CcSEcCtD
Nelarabine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000519	0.000584	CcSEcCtD
Nelarabine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000517	0.000582	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000516	0.00058	CcSEcCtD
Nelarabine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000511	0.000575	CcSEcCtD
Nelarabine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000511	0.000575	CcSEcCtD
Nelarabine—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000509	0.000573	CcSEcCtD
Nelarabine—POLA1—E2F transcription factor network—MYC—peripheral nervous system neoplasm	0.000504	0.00669	CbGpPWpGaD
Nelarabine—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000504	0.000568	CcSEcCtD
Nelarabine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000503	0.000566	CcSEcCtD
Nelarabine—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000502	0.000565	CcSEcCtD
Nelarabine—DGUOK—Metabolism—GNAS—peripheral nervous system neoplasm	0.000498	0.0066	CbGpPWpGaD
Nelarabine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000492	0.000554	CcSEcCtD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	0.000492	0.00652	CbGpPWpGaD
Nelarabine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000491	0.000553	CcSEcCtD
Nelarabine—DGUOK—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000489	0.00648	CbGpPWpGaD
Nelarabine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000488	0.000549	CcSEcCtD
Nelarabine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000486	0.000547	CcSEcCtD
Nelarabine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000486	0.000547	CcSEcCtD
Nelarabine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000485	0.000545	CcSEcCtD
Nelarabine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000484	0.000544	CcSEcCtD
Nelarabine—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000481	0.000541	CcSEcCtD
Nelarabine—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000481	0.000541	CcSEcCtD
Nelarabine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000481	0.000541	CcSEcCtD
Nelarabine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00048	0.00054	CcSEcCtD
Nelarabine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000476	0.000535	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000472	0.000532	CcSEcCtD
Nelarabine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000472	0.000531	CcSEcCtD
Nelarabine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000472	0.000531	CcSEcCtD
Nelarabine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000471	0.00053	CcSEcCtD
Nelarabine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000469	0.000527	CcSEcCtD
Nelarabine—Pain—Etoposide—peripheral nervous system neoplasm	0.000468	0.000526	CcSEcCtD
Nelarabine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000468	0.000526	CcSEcCtD
Nelarabine—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000467	0.000525	CcSEcCtD
Nelarabine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000463	0.000522	CcSEcCtD
Nelarabine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000462	0.00052	CcSEcCtD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—peripheral nervous system neoplasm	0.000455	0.00603	CbGpPWpGaD
Nelarabine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000455	0.000512	CcSEcCtD
Nelarabine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000454	0.00051	CcSEcCtD
Nelarabine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000451	0.000508	CcSEcCtD
Nelarabine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000451	0.000507	CcSEcCtD
Nelarabine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.00045	0.000507	CcSEcCtD
Nelarabine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000449	0.000505	CcSEcCtD
Nelarabine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000448	0.000504	CcSEcCtD
Nelarabine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000447	0.000503	CcSEcCtD
Nelarabine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000447	0.000503	CcSEcCtD
Nelarabine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000446	0.000501	CcSEcCtD
Nelarabine—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000501	CcSEcCtD
Nelarabine—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000501	CcSEcCtD
Nelarabine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000439	0.000494	CcSEcCtD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.000438	0.00581	CbGpPWpGaD
Nelarabine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000436	0.000491	CcSEcCtD
Nelarabine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000434	0.000488	CcSEcCtD
Nelarabine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000432	0.000487	CcSEcCtD
Nelarabine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000432	0.000487	CcSEcCtD
Nelarabine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000429	0.000483	CcSEcCtD
Nelarabine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000429	0.000483	CcSEcCtD
Nelarabine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000428	0.000482	CcSEcCtD
Nelarabine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000426	0.00048	CcSEcCtD
Nelarabine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000425	0.000479	CcSEcCtD
Nelarabine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000424	0.000477	CcSEcCtD
Nelarabine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000423	0.000476	CcSEcCtD
Nelarabine—Headache—Vincristine—peripheral nervous system neoplasm	0.000423	0.000476	CcSEcCtD
Nelarabine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000421	0.000474	CcSEcCtD
Nelarabine—ADA—Metabolism—GNS—peripheral nervous system neoplasm	0.000421	0.00558	CbGpPWpGaD
Nelarabine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.00042	0.000472	CcSEcCtD
Nelarabine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000417	0.00047	CcSEcCtD
Nelarabine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000416	0.000469	CcSEcCtD
Nelarabine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000409	0.00046	CcSEcCtD
Nelarabine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000403	0.000454	CcSEcCtD
Nelarabine—ADA—Metabolism—NME1—peripheral nervous system neoplasm	0.000403	0.00535	CbGpPWpGaD
Nelarabine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000401	0.000451	CcSEcCtD
Nelarabine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000401	0.000451	CcSEcCtD
Nelarabine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000397	0.000447	CcSEcCtD
Nelarabine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000394	0.000444	CcSEcCtD
Nelarabine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000393	0.000443	CcSEcCtD
Nelarabine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000393	0.000442	CcSEcCtD
Nelarabine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000392	0.000442	CcSEcCtD
Nelarabine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000392	0.000441	CcSEcCtD
Nelarabine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000392	0.000441	CcSEcCtD
Nelarabine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000389	0.000438	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	0.000388	0.00515	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GNS—peripheral nervous system neoplasm	0.000388	0.00515	CbGpPWpGaD
Nelarabine—ADA—Metabolism—COX2—peripheral nervous system neoplasm	0.000388	0.00515	CbGpPWpGaD
Nelarabine—Chills—Epirubicin—peripheral nervous system neoplasm	0.000387	0.000436	CcSEcCtD
Nelarabine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00038	0.000427	CcSEcCtD
Nelarabine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000378	0.000426	CcSEcCtD
Nelarabine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000376	0.000423	CcSEcCtD
Nelarabine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000374	0.000421	CcSEcCtD
Nelarabine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000373	0.00042	CcSEcCtD
Nelarabine—DCK—Metabolism—NME1—peripheral nervous system neoplasm	0.000372	0.00493	CbGpPWpGaD
Nelarabine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000371	0.000417	CcSEcCtD
Nelarabine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000368	0.000414	CcSEcCtD
Nelarabine—POLA1—G1/S Transition—MYC—peripheral nervous system neoplasm	0.000366	0.00485	CbGpPWpGaD
Nelarabine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000363	0.000409	CcSEcCtD
Nelarabine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000362	0.000408	CcSEcCtD
Nelarabine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000362	0.000407	CcSEcCtD
Nelarabine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00036	0.000405	CcSEcCtD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	0.00036	0.00477	CbGpPWpGaD
Nelarabine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000358	0.000403	CcSEcCtD
Nelarabine—DCK—Metabolism—COX2—peripheral nervous system neoplasm	0.000358	0.00475	CbGpPWpGaD
Nelarabine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000355	0.000399	CcSEcCtD
Nelarabine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000354	0.000399	CcSEcCtD
Nelarabine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.000394	CcSEcCtD
Nelarabine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000348	0.000391	CcSEcCtD
Nelarabine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.000391	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—AURKA—peripheral nervous system neoplasm	0.000347	0.00461	CbGpPWpGaD
Nelarabine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000347	0.000391	CcSEcCtD
Nelarabine—Headache—Etoposide—peripheral nervous system neoplasm	0.000343	0.000386	CcSEcCtD
Nelarabine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.00034	0.000383	CcSEcCtD
Nelarabine—POLA1—Mitotic M-M/G1 phases—BIRC5—peripheral nervous system neoplasm	0.000337	0.00446	CbGpPWpGaD
Nelarabine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000336	0.000379	CcSEcCtD
Nelarabine—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.000378	CcSEcCtD
Nelarabine—DCK—cerebellum—peripheral nervous system neoplasm	0.000333	0.0349	CbGeAlD
Nelarabine—POLA1—S Phase—MYC—peripheral nervous system neoplasm	0.000332	0.00441	CbGpPWpGaD
Nelarabine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000372	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.00033	0.00437	CbGpPWpGaD
Nelarabine—Cough—Epirubicin—peripheral nervous system neoplasm	0.000328	0.000369	CcSEcCtD
Nelarabine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000328	0.000369	CcSEcCtD
Nelarabine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000366	CcSEcCtD
Nelarabine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000325	0.000366	CcSEcCtD
Nelarabine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.000362	CcSEcCtD
Nelarabine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.00032	0.00036	CcSEcCtD
Nelarabine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.00032	0.00036	CcSEcCtD
Nelarabine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.00032	0.00036	CcSEcCtD
Nelarabine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000311	0.00035	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—CHEK2—peripheral nervous system neoplasm	0.000311	0.00412	CbGpPWpGaD
Nelarabine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000348	CcSEcCtD
Nelarabine—POLA1—Mitotic G1-G1/S phases—MYC—peripheral nervous system neoplasm	0.000308	0.00409	CbGpPWpGaD
Nelarabine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000307	0.000345	CcSEcCtD
Nelarabine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.000344	CcSEcCtD
Nelarabine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000343	CcSEcCtD
Nelarabine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.000341	CcSEcCtD
Nelarabine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000339	CcSEcCtD
Nelarabine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000338	CcSEcCtD
Nelarabine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.0003	0.000338	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000299	0.00397	CbGpPWpGaD
Nelarabine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000333	CcSEcCtD
Nelarabine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000333	CcSEcCtD
Nelarabine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000333	CcSEcCtD
Nelarabine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000292	0.000329	CcSEcCtD
Nelarabine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000322	CcSEcCtD
Nelarabine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000322	CcSEcCtD
Nelarabine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.000319	CcSEcCtD
Nelarabine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000317	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000279	0.000314	CcSEcCtD
Nelarabine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000313	CcSEcCtD
Nelarabine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000313	CcSEcCtD
Nelarabine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000277	0.000312	CcSEcCtD
Nelarabine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000275	0.00031	CcSEcCtD
Nelarabine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000273	0.000308	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	0.000273	0.00362	CbGpPWpGaD
Nelarabine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000273	0.000307	CcSEcCtD
Nelarabine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.000304	CcSEcCtD
Nelarabine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000267	0.0003	CcSEcCtD
Nelarabine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000298	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000298	CcSEcCtD
Nelarabine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000298	CcSEcCtD
Nelarabine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000295	CcSEcCtD
Nelarabine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000295	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.000291	CcSEcCtD
Nelarabine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000289	CcSEcCtD
Nelarabine—ADA—Metabolism—ENO2—peripheral nervous system neoplasm	0.000255	0.00338	CbGpPWpGaD
Nelarabine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000287	CcSEcCtD
Nelarabine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000285	CcSEcCtD
Nelarabine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000284	CcSEcCtD
Nelarabine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000284	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	0.000252	0.00334	CbGpPWpGaD
Nelarabine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000282	CcSEcCtD
Nelarabine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.000278	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.000276	CcSEcCtD
Nelarabine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.000275	CcSEcCtD
Nelarabine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000273	CcSEcCtD
Nelarabine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000273	CcSEcCtD
Nelarabine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000273	CcSEcCtD
Nelarabine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000273	CcSEcCtD
Nelarabine—DCK—Metabolism—ENO2—peripheral nervous system neoplasm	0.000235	0.00312	CbGpPWpGaD
Nelarabine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000263	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000234	0.0031	CbGpPWpGaD
Nelarabine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000261	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—BIRC5—peripheral nervous system neoplasm	0.000225	0.00299	CbGpPWpGaD
Nelarabine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000252	CcSEcCtD
Nelarabine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000252	CcSEcCtD
Nelarabine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000248	CcSEcCtD
Nelarabine—ADA—Metabolism—BCHE—peripheral nervous system neoplasm	0.000215	0.00286	CbGpPWpGaD
Nelarabine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000236	CcSEcCtD
Nelarabine—ADA—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000205	0.00272	CbGpPWpGaD
Nelarabine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000229	CcSEcCtD
Nelarabine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000228	CcSEcCtD
Nelarabine—ADA—Metabolism—TH—peripheral nervous system neoplasm	0.000202	0.00268	CbGpPWpGaD
Nelarabine—DCK—Metabolism—BCHE—peripheral nervous system neoplasm	0.000199	0.00263	CbGpPWpGaD
Nelarabine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000219	CcSEcCtD
Nelarabine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000218	CcSEcCtD
Nelarabine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000216	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000192	0.00254	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.00019	0.00251	CbGpPWpGaD
Nelarabine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000211	CcSEcCtD
Nelarabine—DCK—Metabolism—TH—peripheral nervous system neoplasm	0.000187	0.00248	CbGpPWpGaD
Nelarabine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000205	CcSEcCtD
Nelarabine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000203	CcSEcCtD
Nelarabine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.0002	CcSEcCtD
Nelarabine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.00019	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	0.000167	0.00221	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GNAS—peripheral nervous system neoplasm	0.000165	0.00219	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000162	0.00215	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000162	0.00215	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GNAS—peripheral nervous system neoplasm	0.000153	0.00202	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ABCB1—peripheral nervous system neoplasm	0.00015	0.00198	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	0.000149	0.00198	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—AKT1—peripheral nervous system neoplasm	0.000134	0.00178	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	0.000113	0.0015	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MYC—peripheral nervous system neoplasm	0.000101	0.00134	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—TP53—peripheral nervous system neoplasm	8.31e-05	0.0011	CbGpPWpGaD
Nelarabine—ADA—Metabolism—AKT1—peripheral nervous system neoplasm	4.46e-05	0.000591	CbGpPWpGaD
Nelarabine—DCK—Metabolism—AKT1—peripheral nervous system neoplasm	4.12e-05	0.000546	CbGpPWpGaD
